1-[(1R,2R)-1-[2-(benzotriazol-2-yl)-4-methylphenoxy]-2,3-dihydro-1H-inden-2-yl]-N-methylpyrrolidin-3-amine
C27H29N5O — CID 53378244
Data last refreshed: (MolForge compound catalog, from PubChem)
About 1-[(1R,2R)-1-[2-(benzotriazol-2-yl)-4-methylphenoxy]-2,3-dihydro-1H-inden-2-yl]-N-methylpyrrolidin-3-amine
1-[(1R,2R)-1-[2-(benzotriazol-2-yl)-4-methylphenoxy]-2,3-dihydro-1H-inden-2-yl]-N-methylpyrrolidin-3-amine (PubChem CID 53378244) has the molecular formula C27H29N5O and a molecular weight of 439.56 g/mol. Its IUPAC name is 1-[(1R,2R)-1-[2-(benzotriazol-2-yl)-4-methylphenoxy]-2,3-dihydro-1H-inden-2-yl]-N-methylpyrrolidin-3-amine.
Molecular Properties
| Compound Name | 1-[(1R,2R)-1-[2-(benzotriazol-2-yl)-4-methylphenoxy]-2,3-dihydro-1H-inden-2-yl]-N-methylpyrrolidin-3-amine |
|---|---|
| PubChem CID | 53378244 |
| Molecular Formula | C27H29N5O |
| Molecular Weight | 439.56 g/mol |
| Exact Mass | 439.24 |
| IUPAC Name | 1-[(1R,2R)-1-[2-(benzotriazol-2-yl)-4-methylphenoxy]-2,3-dihydro-1H-inden-2-yl]-N-methylpyrrolidin-3-amine |
| SMILES | CNC1CCN([C@@H]2Cc3ccccc3[C@H]2Oc2ccc(C)cc2-n2nc3ccccc3n2)C1 |
| InChI | InChI=1S/C27H29N5O/c1-18-11-12-26(24(15-18)32-29-22-9-5-6-10-23(22)30-32)33-27-21-8-4-3-7-19(21)16-25(27)31-14-13-20(17-31)28-2/h3-12,15,20,25,27-28H,13-14,16-17H2,1-2H3/t20?,25-,27-/m1/s1 |
| InChIKey | NKNZOKPWPFFHEH-YZPFRRHKSA-N |
| XLogP | 4.07 |
| TPSA | 55.21 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 33 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 439.56 |
| LogP ≤ 5 | 4.07 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 53378244 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.